Carnitine Palmitoyltransferase-I, a New Target for the Treatment of Heart Failure: Perspectives on a Shift in Myocardial Metabolism as a Therapeutic Intervention

By Sushma A. Mengi   Naranjan S. Dhalla  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 201-209

Adis International

Access to resources Recommend Favorite

Effects of carnitine palmitoyltransferase I inhibitors on hepatic hypertrophy

By Yotsumoto T.   Naitoh T.   Kitahara M.   Tsuruzoe N.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 297-302

Elsevier

Access to resources Recommend Favorite

Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176

By Hamdan M.   Urien S.   Le Louet H.   Tillement J-P.   Morin D.  

Pharmacological Research, Vol. 44, Iss. 2, 2001-08 ,pp. : 99-104

Academic Press

Access to resources Recommend Favorite

Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats

By Mori T.   Nishimura H.   Okabe M.   Ueyama M.   Kubota J.   Kawamura K.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite

Improved survival with simendan after experimental myocardial infarction in rats

By Levijoki J.   Pollesello P.   Kaheinen P.   Haikala H.  

European Journal of Pharmacology, Vol. 419, Iss. 2, 2001-05 ,pp. : 243-248

Elsevier

Access to resources Recommend Favorite